Showing results (1111-1120 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|July 1, 1988
The non-linear pharmacokinetics of prednisone and prednisolone. III. Experiments using the rabbit as an animal modelJ J Ferry, J G WagnerBiopharmaceutics & Drug Disposition|July 1, 1988
Choice of optimum pharmacokinetic model of orally administered paracetamolJ L Pedraz, M B Calvo, J M Lanao, et al.Biopharmaceutics & Drug Disposition|October 21, 2020
Mechanistic evaluation of the effect of sodium-dependent glucose transporter 2 inhibitors on delayed glucose absorption in patients with type 2 diabetes mellitus using a quantitative systems pharmacology model of human systemic glucose dynamicsKazumi Mori-Anai, Yoshihiko Tashima, Tomohisa Nakada, et al.Biopharmaceutics & Drug Disposition|March 19, 2020
Applicability of the Øie-Tozer model to predict three types of distribution volume (Vd) in humans: Vd in central compartment, Vd at steady state, and Vd at beta phaseMasahiro Yahata, Yuji Ishii, Tetsuya Nakagawa, et al.Biopharmaceutics & Drug Disposition|September 1, 1988
Pharmacokinetics of 14C-etretinate in healthy volunteers and two patients with biliary T-tube drainageR W Lucek, J Dickerson, D E Carter, et al.Biopharmaceutics & Drug Disposition|October 1, 1985
Selective incorporation of asialofetuin into hepatocyte of ratY Aramaki, A Inaba, S TsuchiyaBiopharmaceutics & Drug Disposition|January 8, 2022
Influence of piperine and omeprazole on the regional absorption of Daclatasvir from rabbit intestineShimaa M Ashmawy, Dina A Eltahan, Mohamed A Osman, et al.Biopharmaceutics & Drug Disposition|March 24, 2021
When special populations intersect with drug-drug interactions: Application of physiologically-based pharmacokinetic modeling in pregnant populationsCaroline Sychterz, Aleksandra Galetin, Kunal S TaskarBiopharmaceutics & Drug Disposition|December 8, 2016
Physiologically based pharmacokinetic modeling revealed minimal codeine intestinal metabolism in first-pass removal in ratsKeumhan Noh, Shu Chen, Qi J Yang, et al.Biopharmaceutics & Drug Disposition|December 8, 2016
Inhibition of glucuronidation and oxidative metabolism of buprenorphine using GRAS compounds or dietary constituents/supplements: in vitro proof of conceptNeha V Maharao, Anand A Joshi, Phillip M GerkPageof 214